Pierzynowska, K., Deshpande, A., Mosiichuk, N., Terkeltaub, R., Szczurek, P., Salido, E., . . . Grujic, D. (2020). Oral Treatment With an Engineered Uricase, ALLN-346, Reduces Hyperuricemia, and Uricosuria in Urate Oxidase-Deficient Mice. Front Med (Lausanne).

Pierzynowska, Kateryna, Aditi Deshpande, Nadiia Mosiichuk, Robert Terkeltaub, Paulina Szczurek, Eduardo Salido, Stefan Pierzynowski, and Danica Grujic. "Oral Treatment With an Engineered Uricase, ALLN-346, Reduces Hyperuricemia, and Uricosuria in Urate Oxidase-Deficient Mice." Front Med (Lausanne) 2020.

Pierzynowska, Kateryna, et al. "Oral Treatment With an Engineered Uricase, ALLN-346, Reduces Hyperuricemia, and Uricosuria in Urate Oxidase-Deficient Mice." Front Med (Lausanne) 2020.